Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia. Issue 6 (3rd November 2022)

• Record Type: Journal Article
• Authors: Okada, Tsuyoshi; Hori, Hikaru; Hasegawa, Naomi; Murata, Atsunobu; Kyou, Yoshitaka; Kodaka, Fumitoshi; Iida, Hitoshi; Ochi, Shinichiro; Takaesu, Yoshikazu; Tsuboi, Takashi; Iga, Jun-ichi; Ichihashi, Kayo; Muraoka, Hiroyuki; Furihata, Ryuji; Yasui-Furukori, Norio; Usami, Masahide; Onitsuka, Toshiaki; Ogasawara, Kazuyoshi; Tagata, Hiromi; Takeshima, Masahiro; Ohi, Kazutaka; Numata, Shusuke; Hashimoto, Naoki; Yamada, Hiroki; Makinodan, Manabu; Komatsu, Hiroshi; Hishimoto, Akitoyo; Yamagata, Hirotaka; Kido, Mikio; Kubota, Chika; Atake, Kiyokazu; Yamada, Hisashi; Nagasawa, Tatsuya; Matsumoto, Junya; Miura, Kenichiro; Inada, Ken; Watanabe, Koichiro; Suda, Shiro; Hashimoto, Ryota;
• Is Part Of: Journal of clinical psychopharmacology. Volume 42:Issue 6(2022)
• Page Start: 591
• Page End: 593
• Publication Date: 2022-11-03
• Subjects: Psychopharmacology -- Periodicals; Psychopharmacology -- Periodicals; Psychopharmacologie -- Périodiques; Psychopharmacology; Periodicals; 615.78
• DOI: 10.1097/JCP.0000000000001604
• Languages: English
• ISSNs: 0271-0749